Format
Sort by
Items per page

Send to

Choose Destination

Best matches for D’Amato RJ[au]:

Epsin deficiency promotes lymphangiogenesis through regulation of VEGFR3 degradation in diabetes. Wu H et al. J Clin Invest. (2018)

A novel strategy to enhance angiogenesis in vivo using the small VEGF-binding peptide PR1P. Adini A et al. Angiogenesis. (2017)

Thalidomide is an inhibitor of angiogenesis. D'Amato RJ et al. Proc Natl Acad Sci U S A. (1994)

Search results

Items: 1 to 50 of 93

1.

PR1P ameliorates neurodegeneration through activation of VEGF signaling pathway and remodeling of the extracellular environment.

Chi ZL, Adini A, Birsner AE, Bazinet L, Akula JD, D'Amato RJ.

Neuropharmacology. 2019 Apr;148:96-106. doi: 10.1016/j.neuropharm.2018.12.029. Epub 2018 Dec 27.

PMID:
30594697
2.

Epsin deficiency promotes lymphangiogenesis through regulation of VEGFR3 degradation in diabetes.

Wu H, Rahman HNA, Dong Y, Liu X, Lee Y, Wen A, To KH, Xiao L, Birsner AE, Bazinet L, Wong S, Song K, Brophy ML, Mahamud MR, Chang B, Cai X, Pasula S, Kwak S, Yang W, Bischoff J, Xu J, Bielenberg DR, Dixon JB, D'Amato RJ, Srinivasan RS, Chen H.

J Clin Invest. 2018 Aug 31;128(9):4025-4043. doi: 10.1172/JCI96063. Epub 2018 Aug 13.

3.

Identification of Padi2 as a novel angiogenesis-regulating gene by genome association studies in mice.

Khajavi M, Zhou Y, Birsner AE, Bazinet L, Rosa Di Sant A, Schiffer AJ, Rogers MS, Krishnaji ST, Hu B, Nguyen V, Zon L, D'Amato RJ.

PLoS Genet. 2017 Jun 15;13(6):e1006848. doi: 10.1371/journal.pgen.1006848. eCollection 2017 Jun.

4.

A novel strategy to enhance angiogenesis in vivo using the small VEGF-binding peptide PR1P.

Adini A, Adini I, Chi ZL, Derda R, Birsner AE, Matthews BD, D'Amato RJ.

Angiogenesis. 2017 Aug;20(3):399-408. doi: 10.1007/s10456-017-9556-7. Epub 2017 Apr 10.

PMID:
28397127
5.

Cellular mechanism of oral absorption of solidified polymer micelles.

Abramov E, Cassiola F, Schwob O, Karsh-Bluman A, Shapero M, Ellis J, Luyindula D, Adini I, D'Amato RJ, Benny O.

Nanomedicine. 2015 Nov;11(8):1993-2002. doi: 10.1016/j.nano.2015.07.008. Epub 2015 Aug 3.

PMID:
26247432
6.

Melanocyte pigmentation inversely correlates with MCP-1 production and angiogenesis-inducing potential.

Adini I, Adini A, Bazinet L, Watnick RS, Bielenberg DR, D'Amato RJ.

FASEB J. 2015 Feb;29(2):662-70. doi: 10.1096/fj.14-255398. Epub 2014 Nov 18.

7.

Characterization of a spontaneous retinal neovascular mouse model.

Hasegawa E, Sweigard H, Husain D, Olivares AM, Chang B, Smith KE, Birsner AE, D'Amato RJ, Michaud NA, Han Y, Vavvas DG, Miller JW, Haider NB, Connor KM.

PLoS One. 2014 Sep 4;9(9):e106507. doi: 10.1371/journal.pone.0106507. eCollection 2014.

8.

The corneal micropocket assay: a model of angiogenesis in the mouse eye.

Birsner AE, Benny O, D'Amato RJ.

J Vis Exp. 2014 Aug 16;(90). doi: 10.3791/51375.

9.

Melanocyte-secreted fibromodulin promotes an angiogenic microenvironment.

Adini I, Ghosh K, Adini A, Chi ZL, Yoshimura T, Benny O, Connor KM, Rogers MS, Bazinet L, Birsner AE, Bielenberg DR, D'Amato RJ.

J Clin Invest. 2014 Jan;124(1):425-36. doi: 10.1172/JCI69404. Epub 2013 Dec 20.

10.

Pomalidomide is strongly antiangiogenic and teratogenic in relevant animal models.

D'Amato RJ, Lentzsch S, Rogers MS.

Proc Natl Acad Sci U S A. 2013 Dec 10;110(50):E4818. doi: 10.1073/pnas.1315875110. Epub 2013 Dec 3. No abstract available.

11.

Suppression of autoimmune retinal inflammation by an antiangiogenic drug.

Yoshimura T, Benny O, Bazinet L, D'Amato RJ.

PLoS One. 2013 Jun 13;8(6):e66219. doi: 10.1371/journal.pone.0066219. Print 2013.

12.

The albino mutation of tyrosinase alters ocular angiogenic responsiveness.

Rogers MS, Adini I, McBride AF, Birsner AE, D'Amato RJ.

Angiogenesis. 2013 Jul;16(3):639-46. doi: 10.1007/s10456-013-9342-0. Epub 2013 Feb 20.

13.

Vascular endothelial growth factor C is increased in endometrium and promotes endothelial functions, vascular permeability and angiogenesis and growth of endometriosis.

Xu H, Zhang T, Man GC, May KE, Becker CM, Davis TN, Kung AL, Birsner AE, D'Amato RJ, Wong AW, Wang CC.

Angiogenesis. 2013 Jul;16(3):541-51. doi: 10.1007/s10456-013-9333-1. Epub 2013 Jan 19.

PMID:
23334337
14.

The stem cell marker prominin-1/CD133 interacts with vascular endothelial growth factor and potentiates its action.

Adini A, Adini I, Ghosh K, Benny O, Pravda E, Hu R, Luyindula D, D'Amato RJ.

Angiogenesis. 2013 Apr;16(2):405-16. doi: 10.1007/s10456-012-9323-8. Epub 2012 Nov 13.

PMID:
23150059
15.

Common polymorphisms in angiogenesis.

Rogers MS, D'Amato RJ.

Cold Spring Harb Perspect Med. 2012 Nov 1;2(11). pii: a006510. doi: 10.1101/cshperspect.a006510. Review.

16.

The classical pink-eyed dilution mutation affects angiogenic responsiveness.

Rogers MS, Boyartchuk V, Rohan RM, Birsner AE, Dietrich WF, D'Amato RJ.

PLoS One. 2012;7(5):e35237. doi: 10.1371/journal.pone.0035237. Epub 2012 May 15.

17.

VEGF, PF4 and PDGF are elevated in platelets of colorectal cancer patients.

Peterson JE, Zurakowski D, Italiano JE Jr, Michel LV, Connors S, Oenick M, D'Amato RJ, Klement GL, Folkman J.

Angiogenesis. 2012 Jun;15(2):265-73. doi: 10.1007/s10456-012-9259-z. Epub 2012 Mar 9.

PMID:
22402885
18.

Forty-year journey of angiogenesis translational research.

Cao Y, Arbiser J, D'Amato RJ, D'Amore PA, Ingber DE, Kerbel R, Klagsbrun M, Lim S, Moses MA, Zetter B, Dvorak H, Langer R.

Sci Transl Med. 2011 Dec 21;3(114):114rv3. doi: 10.1126/scitranslmed.3003149. Review.

PMID:
22190240
19.

A morphometric study of mechanotransductively induced dermal neovascularization.

Erba P, Miele LF, Adini A, Ackermann M, Lamarche JM, Orgill BD, D'Amato RJ, Konerding MA, Mentzer SJ, Orgill DP.

Plast Reconstr Surg. 2011 Oct;128(4):288e-299e. doi: 10.1097/PRS.0b013e3182268b19.

20.

Green tea epigallocatechin-3-gallate inhibits angiogenesis and suppresses vascular endothelial growth factor C/vascular endothelial growth factor receptor 2 expression and signaling in experimental endometriosis in vivo.

Xu H, Becker CM, Lui WT, Chu CY, Davis TN, Kung AL, Birsner AE, D'Amato RJ, Wai Man GC, Wang CC.

Fertil Steril. 2011 Oct;96(4):1021-8. doi: 10.1016/j.fertnstert.2011.07.008. Epub 2011 Aug 6.

PMID:
21821246
21.

Circulating endothelial progenitor cells are up-regulated in a mouse model of endometriosis.

Becker CM, Beaudry P, Funakoshi T, Benny O, Zaslavsky A, Zurakowski D, Folkman J, D'Amato RJ, Ryeom S.

Am J Pathol. 2011 Apr;178(4):1782-91. doi: 10.1016/j.ajpath.2010.12.037.

22.

Angiogenesis in wounds treated by microdeformational wound therapy.

Erba P, Ogawa R, Ackermann M, Adini A, Miele LF, Dastouri P, Helm D, Mentzer SJ, D'Amato RJ, Murphy GF, Konerding MA, Orgill DP.

Ann Surg. 2011 Feb;253(2):402-9. doi: 10.1097/SLA.0b013e31820563a8.

23.

Broad spectrum antiangiogenic treatment for ocular neovascular diseases.

Benny O, Nakai K, Yoshimura T, Bazinet L, Akula JD, Nakao S, Hafezi-Moghadam A, Panigrahy D, Pakneshan P, D'Amato RJ.

PLoS One. 2010 Sep 1;5(9). pii: e12515. doi: 10.1371/journal.pone.0012515.

24.

Genetic loci that control the size of laser-induced choroidal neovascularization.

Nakai K, Rogers MS, Baba T, Funakoshi T, Birsner AE, Luyindula DS, D'Amato RJ.

FASEB J. 2009 Jul;23(7):2235-43. doi: 10.1096/fj.08-124321. Epub 2009 Feb 23.

25.

Matrigel cytometry: a novel method for quantifying angiogenesis in vivo.

Adini A, Fainaru O, Udagawa T, Connor KM, Folkman J, D'Amato RJ.

J Immunol Methods. 2009 Mar 15;342(1-2):78-81. doi: 10.1016/j.jim.2008.11.016. Epub 2008 Dec 25.

PMID:
19109967
26.

An orally delivered small-molecule formulation with antiangiogenic and anticancer activity.

Benny O, Fainaru O, Adini A, Cassiola F, Bazinet L, Adini I, Pravda E, Nahmias Y, Koirala S, Corfas G, D'Amato RJ, Folkman J.

Nat Biotechnol. 2008 Jul;26(7):799-807. doi: 10.1038/nbt1415. Epub 2008 Jun 29.

27.

Differential suppression of vascular permeability and corneal angiogenesis by nonsteroidal anti-inflammatory drugs.

Pakneshan P, Birsner AE, Adini I, Becker CM, D'Amato RJ.

Invest Ophthalmol Vis Sci. 2008 Sep;49(9):3909-13. doi: 10.1167/iovs.07-1527. Epub 2008 May 16.

PMID:
18487370
28.

Dendritic cells augment choroidal neovascularization.

Nakai K, Fainaru O, Bazinet L, Pakneshan P, Benny O, Pravda E, Folkman J, D'Amato RJ.

Invest Ophthalmol Vis Sci. 2008 Aug;49(8):3666-70. doi: 10.1167/iovs.07-1640. Epub 2008 Apr 11.

PMID:
18408184
29.

2-methoxyestradiol inhibits hypoxia-inducible factor-1{alpha} and suppresses growth of lesions in a mouse model of endometriosis.

Becker CM, Rohwer N, Funakoshi T, Cramer T, Bernhardt W, Birsner A, Folkman J, D'Amato RJ.

Am J Pathol. 2008 Feb;172(2):534-44. doi: 10.2353/ajpath.2008.061244. Epub 2008 Jan 17.

30.

The mouse cornea micropocket angiogenesis assay.

Rogers MS, Birsner AE, D'Amato RJ.

Nat Protoc. 2007;2(10):2545-50.

PMID:
17947997
31.

Mutant anthrax toxin B moiety (protective antigen) inhibits angiogenesis and tumor growth.

Rogers MS, Christensen KA, Birsner AE, Short SM, Wigelsworth DJ, Collier RJ, D'Amato RJ.

Cancer Res. 2007 Oct 15;67(20):9980-5.

32.

Dendritic cells support angiogenesis and promote lesion growth in a murine model of endometriosis.

Fainaru O, Adini A, Benny O, Adini I, Short S, Bazinet L, Nakai K, Pravda E, Hornstein MD, D'Amato RJ, Folkman J.

FASEB J. 2008 Feb;22(2):522-9. Epub 2007 Sep 14.

PMID:
17873101
33.

Angiogenesis and antiangiogenic therapy in endometriosis.

Becker CM, D'Amato RJ.

Microvasc Res. 2007 Sep-Nov;74(2-3):121-30. Epub 2007 May 6. Review.

PMID:
17574280
34.

Chronic suppression of angiogenesis following radiation exposure is independent of hematopoietic reconstitution.

Udagawa T, Birsner AE, Wood M, D'Amato RJ.

Cancer Res. 2007 Mar 1;67(5):2040-5.

35.

Antiangiogenic effect of oral 2-methoxyestradiol on choroidal neovascularization in mice.

Funakoshi T, Birsner AE, D'Amato RJ.

Exp Eye Res. 2006 Nov;83(5):1102-7. Epub 2006 Jul 7.

PMID:
16828472
36.

A novel noninvasive model of endometriosis for monitoring the efficacy of antiangiogenic therapy.

Becker CM, Wright RD, Satchi-Fainaro R, Funakoshi T, Folkman J, Kung AL, D'Amato RJ.

Am J Pathol. 2006 Jun;168(6):2074-84.

37.

Short synthetic endostatin peptides inhibit endothelial migration in vitro and endometriosis in a mouse model.

Becker CM, Sampson DA, Short SM, Javaherian K, Folkman J, D'Amato RJ.

Fertil Steril. 2006 Jan;85(1):71-7.

PMID:
16412733
38.

Analysis of tumor-associated stromal cells using SCID GFP transgenic mice: contribution of local and bone marrow-derived host cells.

Udagawa T, Puder M, Wood M, Schaefer BC, D'Amato RJ.

FASEB J. 2006 Jan;20(1):95-102.

PMID:
16394272
39.

The effect of genetic diversity on angiogenesis.

Rogers MS, D'Amato RJ.

Exp Cell Res. 2006 Mar 10;312(5):561-74. Review.

PMID:
16321383
40.

Endostatin inhibits the growth of endometriotic lesions but does not affect fertility.

Becker CM, Sampson DA, Rupnick MA, Rohan RM, Efstathiou JA, Short SM, Taylor GA, Folkman J, D'Amato RJ.

Fertil Steril. 2005 Oct;84 Suppl 2:1144-55.

PMID:
16210006
41.

X-linked dominant growth suppression of transplanted tumors in C57BL/6J-scid mice.

Wood M, Udagawa T, Hida Y, D'Amato RJ.

Cancer Res. 2005 Jul 1;65(13):5690-5.

42.

Nonsteroidal antiinflammatory drugs differentially suppress endometriosis in a murine model.

Efstathiou JA, Sampson DA, Levine Z, Rohan RM, Zurakowski D, Folkman J, D'Amato RJ, Rupnick MA.

Fertil Steril. 2005 Jan;83(1):171-81.

PMID:
15652904
43.

Genetic heterogeneity of the vasculogenic phenotype parallels angiogenesis; Implications for cellular surrogate marker analysis of antiangiogenesis.

Shaked Y, Bertolini F, Man S, Rogers MS, Cervi D, Foutz T, Rawn K, Voskas D, Dumont DJ, Ben-David Y, Lawler J, Henkin J, Huber J, Hicklin DJ, D'Amato RJ, Kerbel RS.

Cancer Cell. 2005 Jan;7(1):101-11.

44.

Exogenous control of mammalian gene expression through modulation of RNA self-cleavage.

Yen L, Svendsen J, Lee JS, Gray JT, Magnier M, Baba T, D'Amato RJ, Mulligan RC.

Nature. 2004 Sep 23;431(7007):471-6.

PMID:
15386015
45.

Genetic loci that control the angiogenic response to basic fibroblast growth factor.

Rogers MS, Rohan RM, Birsner AE, D'Amato RJ.

FASEB J. 2004 Jul;18(10):1050-9. Erratum in: FASEB J. 2015 Jan;29(1):354-5.

PMID:
15226265
46.

Long-term remission of Crohn's disease treated with thalidomide: a seminal case report.

Fishman SJ, Feins NR, D' Amato RJ, Folkman J.

Angiogenesis. 1999;3(3):201-4.

PMID:
14535285
47.

Genetic loci that control vascular endothelial growth factor-induced angiogenesis.

Rogers MS, Rohan RM, Birsner AE, D'Amato RJ.

FASEB J. 2003 Nov;17(14):2112-4. Epub 2003 Sep 4.

PMID:
12958152
48.

Persistence of microscopic human cancers in mice: alterations in the angiogenic balance accompanies loss of tumor dormancy.

Udagawa T, Fernandez A, Achilles EG, Folkman J, D'Amato RJ.

FASEB J. 2002 Sep;16(11):1361-70.

PMID:
12205027
49.

Injection of antiangiogenic agents into the macaque preovulatory follicle: disruption of corpus luteum development and function.

Hazzard TM, Rohan RM, Molskness TA, Fanton JW, D'Amato RJ, Stouffer RL.

Endocrine. 2002 Apr;17(3):199-206.

PMID:
12108520
50.

S-3-Amino-phthalimido-glutarimide inhibits angiogenesis and growth of B-cell neoplasias in mice.

Lentzsch S, Rogers MS, LeBlanc R, Birsner AE, Shah JH, Treston AM, Anderson KC, D'Amato RJ.

Cancer Res. 2002 Apr 15;62(8):2300-5.

Supplemental Content

Loading ...
Support Center